🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8927030

Use of nitrite salts for the treatment of cardiovascular conditions

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8926987

Replication-competent adenoviral vectors

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8926986

Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921340

Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases o

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921323

Methods and compositions for modulating BCL-2 family polypeptides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921097

Methods for expression and purification of immunotoxins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921071

Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infecti

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921050

Methods of diagnosing renal cell carcinoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8920807

Vault complexes for cytokine delivery

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916596

Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhib

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916556

Pharmaceutical formulations comprising neurotrophin mimetics

The United States of America represented by the Department of Vetran Affairs · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916570

A3 adenosine receptor agonists and antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916175

Safer attenuated varicella-zoster virus vaccines with missing or diminished latency of inf

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916172

MVA expressing modified HIV envelope, gag, and pol genes

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8916159

Selenocysteine mediated hybrid antibody molecules

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8912316

Compositions and methods for inhibiting expression of CD45 gene

The Government of the United States, as Respresented by the Secretary of the Army · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8912214

Use of Chk2 kinase inhibitors for cancer treatment

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8912146

Derivatives of APF and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911742

Transcutaneous immunization without heterologous adjuvant

The United States of America as represented by the Secretary of the Army · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8911728

High-affinity fully functional soluble single-domain human CD4, antibodies, and related fu

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8907060

Mutated Pseudomonas exotoxins with reduced antigenicity

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8906384

Antiviral activity of bovine type III interferon against foot-and-mouth disease virus

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8906358

Leishmania challenge model

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8905913

Method and composition for synchronizing time of insemination

JBS United Animal Health II LLC · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted